期刊文献+

阿昔莫司对oxLDL诱导泡沫细胞自噬及AMPK/mTOR通路的影响

Effects of acipimox on oxLDL-induced foam cells autophagy and AMPK/mTOR pathway
下载PDF
导出
摘要 目的基于AMPK/mTOR通路探讨阿昔莫司对氧化低密度脂蛋白(oxLDL)诱导泡沫细胞自噬的影响。方法体外培养THP-1细胞株(人单核细胞株),使用佛波醇酯促进其分化形成巨噬细胞,将巨噬细胞分为空白组、对照组、阿昔莫司组、氯喹组、阿昔莫司+氯喹组、Compound C(AMPK抑制剂)组、阿昔莫司+Compound C组。各组均添加对应药物作用于细胞0.5 h,除空白组外,其余组再添加oxLDL培养48 h。使用油红O染色检测细胞内脂滴含量;使用透射电子显微镜观察细胞中自噬体变化;采用免疫印迹法(Western Blot)检测细胞中自噬相关蛋白(LC3Ⅱ/LC3Ⅰ、P62)及AMPK/mTOR通路相关蛋白(p-AMPK/AMPK、p-mTOR/mTOR)水平。结果与空白组比较,对照组细胞红色脂滴含量升高(P<0.05),自噬体数量明显增多。与对照组比较,阿昔莫司组LC3Ⅱ/LC3Ⅰ水平升高,P62水平降低(P<0.05),而氯喹组LC3Ⅱ/LC3Ⅰ水平降低,P62水平升高(P<0.05);与阿昔莫司组比较,阿昔莫司+氯喹组LC3Ⅱ/LC3Ⅰ水平降低,P62水平升高(P<0.05)。与对照组相比,阿昔莫司组p-AMPK/AMPK、LC3Ⅱ/LC3Ⅰ水平升高,p-mTOR/mTOR、P62水平降低(P<0.05),而Compound C组p-AMPK/AMPK、LC3Ⅱ/LC3Ⅰ水平降低,p-mTOR/mTOR、P62水平升高(P<0.05);与阿昔莫司组比较,阿昔莫司+Compound C组p-AMPK/AMPK、LC3Ⅱ/LC3Ⅰ水平降低,p-mTOR/mTOR、P62水平升高(P<0.05)。结论阿昔莫司可以促进oxLDL诱导泡沫细胞自噬过程,且此过程可能与调控AMPK/mTOR通路有关。 Objective To investigate the effects of acipimox on oxLDL-induced foam cells autophagy and AMPK/mTOR pathway.Methods THP-1 cell line(human monocyte cell line)were cultured in vitro,which were promoted to differentiate into macrophages by using phorbol ester.The macrophages were divided into blank group,control group,acipimox group,and chloroquine group,acipimox+chloroquine group,compound C(AMPK inhibitor)group,acipimox+compound C group.The corresponding drugs were added to the cells for 0.5h.Then except for blank group,the other groups were added with oxidized low-density lipoprotein(oxLDL)and cultured for 48h,then oil red O staining was used to detect the content of lipid droplets in cells;transmission electron microscope was used to observe the changes of autophagosomes in cells;Western Blot was used to detect the levels of autophagy-related proteins(LC3Ⅱ/LC3Ⅰ,P62)and AMPK/mTOR pathway related proteins(p-AMPK/AMPK,p-mTOR/mTOR)in cells.Results Compared with those in blank group,the levels of red lipid droplets and the number of autophagosomes in control group were significantly increased(P<0.05).Compared with those in control group,the levels of LC3Ⅱ/LC3Ⅰin acipimox group were significantly increased,however,P62 levels were significantly decreased(P<0.05),and the levels of LC3Ⅱ/LC3Ⅰin chloroquine group were significantly decreased,but P62 levels were significantly increased(P<0.05).Compared with those in acipimox group,the levels of LC3Ⅱ/LC3Ⅰin the acipolimus+chloroquine group were significantly decreased,however,P62 levels were significantly increased(P<0.05).Compared with those in control group,the levels of p-AMPK/AMPK and LC3Ⅱ/LC3Ⅰin acipimox group were significantly increased,while,the levels of p-mTOR/mTOR and P62 were significantly decreased(P<0.05).Moreover the levels of p-AMPK/AMPK and LC3Ⅱ/LC3Ⅰin Compound C group were significantly decreased,however,the levels of p-mTOR/mTOR and P62 were significantly increased(P<0.05).Compared with those in acipolimus group,the levels of p-AMPK/AMPK and LC3Ⅱ/LC3Ⅰin acipolimus+compound C group were significantly decreased,but,the levels of p-mTOR/mTOR and P62 were significantly increased(P<0.05).Conclusion Acipimox can promote the autophagy process of foam cells induced by oxLDL,and its action mechanism may be related to the regulation of AMPK/mTOR pathway.
作者 杨少君 周乃珍 王晓霞 YANG Shaojun;ZHOU Naizhen;WANG Xiaoxia(Department of Cardiology,Zhongshan Hospital Affiliated to Xiamen University,Fujian,Xiamen 361004,China;不详)
出处 《河北医药》 CAS 2022年第10期1500-1503,共4页 Hebei Medical Journal
关键词 阿昔莫司 OXLDL 泡沫细胞 自噬 AMPK/mTOR通路 acipimox oxLDL foam cells autophagy AMPK/mTOR pathway
  • 相关文献

参考文献9

二级参考文献78

  • 1唐猛.内皮祖细胞与心血管缺血性疾病的研究进展[J].中国医药导报,2006,3(11):126-128. 被引量:1
  • 2Zhao Y, Pennings M, Hildebrand RB, et al. Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCAI and SR-BI in bone marrow- derived cells in LDL receptor knockout mice on western-type diet [J]. Cire Res, 2010, 107 (12): e20-e31.
  • 3Chung S, Gebre AK, Seo J, et al. A novel role for ABCA1- generated large pre-β migrating nascent HDL in the regulation of hepatic VLDL triglyeeride secretion [J]. J Lipid Res, 2010, 51 (4): 729-742.
  • 4Teupser D, Kretzscbmar D, Tenne C, et al. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atheroselerosis in LDL-reeeptor defieient mice [J]. Arterios-cler Thromb Vase Biol, 2008, 28 ( 11 ): 2009-2015.
  • 5Kawata AK, Revieki DA, Thakkar R, et al. Flushing assessment tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinieal impaet of niacin therapy [J]. Clin Drug Investig, 2009, 29 (4) : 215-229.
  • 6Chen K, Febbraio M, Li W, etal. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density-lipoprotein[J]. Cire Res, 2008, 102(12): 1512-1519.
  • 7Fitzgerald ML, Mujawar Z, Tamehiro N. ABC transporters, athe- roselerosis and inflammation [ J ]. Atheroselerosis, 2010, 211 ( 2 ): 361-370.
  • 8Azuma Y, Takada M, Shin HW, et al. Retroendoeytosis pathway of ABCAI/apoA-I contributes to HDL formation[J]. Genes Cells, 2009, 14 (2): 191-204.
  • 9Kratzer A, Buchebner M, Pfeifer T, et al. Synthetic LXR agonist attenuates plaque formation in apoE-/-mice without inducing liver steatosis and hypertriglyceridemia[J]. J Lipid Res, 2009, 50 (2): 312-326.
  • 10Robinson JG. Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin [J]. Vascular Health Risk Manag, 2009, 5( 1 ): 3143.

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部